Novartis AG Common Stock (NVS)

Net Receivables

$9.85B

Quarterly · Period ending: · USD

NVS logo

NVS Net Receivables

Latest reported$9.85B
NVS Quarterly Net Receivables ($6.34B → $9.85B)
High-resolution chart · PNG

NVS net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
6,338,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.